Association of the NAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects

Gynecologic Oncology

Volumn 96, Issue 2, 2005, Pages 423-429

  Niwa, Yoshimitsu ^a   Hirose, Kaoru ^b   Nakanishi, Toru ^b   Nawa, Akihiro ^b   Kuzuya, Kazuo ^b   Tajima, Kazuo ^b   Hamajima, Nobuyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cervical cancer; Genetic polymorphism; NAD(P)H

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE:QUINONE OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; JAPAN; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 12344328266     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.10.015     Document Type: Article

References (52)

1. M. Scheffner, B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1990 1129 1136
2. K. Münger, W.C. Phelps, V. Bubb, P.M. Howley, and R. Schlegel The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes J. Virol. 63 1989 4417 4421
3. W. Winkelstein Smoking and cervical cancer-current status: a review Am. J. Epidemiol. 131 1990 945 957
4. J.R. Daling, K.J. Sherman, T. Gregory Hislop, C. Maden, M.T. Mandelson, and A.M. Beckmann Cigarette smoking and the risk of anogenital cancer Am. J. Epidemiol. 135 1992 180 189
5. B. Prokopczyk, J.E. Cox, D. Hoffmann, and S.E. Waggoner Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers J. Natl. Cancer Inst. 89 1997 868 873
6. Y. Haupt, R. Maya, A. Kazaz, and M. Oren Mdm2 promotes the rapid degradation of p53 Nature 387 1997 296 299
7. M.H. Kubbutat, S.N. Jones, and K.H. Vousden Regulation of p53 stability by Mdm2 Nature 387 1997 299 303
8. G. Asher, J. Lotem, L. Sachs, C. Kahana, and Y. Shaul Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1 Proc. Natl. Acad. Sci. U. S. A. 99 2002 13125 13130
9. G. Asher, J. Lotem, B. Cohen, L. Sachs, and Y. Shaul Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1 Proc. Natl. Acad. Sci. U. S. A. 98 2001 1188 1193
10. G. Asher, J. Lotem, R. Kama, L. Sachs, and Y. Shaul NQO1 stabilizes p53 through a distinct pathway Proc. Natl. Acad. Sci. U. S. A. 99 2002 3099 3104
11. G. Asher, J. Lotem, P. Tsvetkov, V. Reiss, L. Sachs, and Y. Shaul p53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H: quinone oxidoreductase 1 Proc. Natl. Acad. Sci. U. S. A. 100 2003 15065 15070
12. P. Joseph, and A.K. Jaiswal NAD(P)H: quinone oxidoreductase 1 (DT-diaphorase) specifically prevents the formation of benzo[á]pyrene quinone-DNA adducts generated by cytochrome P450 1A1 and P450 reductase Proc. Natl. Acad. Sci. U. S. A. 91 1994 8413 8417
13. A.K. Jaiswal Human NAD(P)H: quinone oxidoreductase (NQO1) gene structure and induction by dioxin Biochemistry 30 1991 10647 10653
14. R.D. Traver, T. Horikoshi, K.D. Danenberg, T.H. Stadlbauer, P.V. Danenberg, and D. Ross NAD(P)H: quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity Cancer Res. 52 1992 797 802
15. D. Siegel, A. Anwar, S. Winski, J.K. Kepa, K.L. Zolman, and D. Ross Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H: quinine oxidoreductase 1 Mol. Pharmacol. 59 2001 263 268
16. J.L. Wiemels, A. Pagnanmenta, G.M. Taylor, O.B. Eden, F.E. Alexander, and M.F. Greaves A lack of a functional NAD(P)H: quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom childhood cancer study investigators Cancer Res. 59 1999 4095 4099
17. R.A. Larson, Y. Wang, M. Banerjee, J. Wiemels, C. Harford, and M.M. Le Beau NAD(P)H: quinone oxidoreductase gene in patients with primary and therapy-related myeloid leukemia Blood 94 1999 803 807
18. T. Naoe, K. Takeyama, T. Yokozawa, H. Kiyoi, M. Seto, and N. Uike Analysis of genetic polymorphism in NQO1, GST-M1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia Clin. Cancer Res. 6 2000 4091 4095
19. M.T. Smith, Y. Wang, E. Kane, S. Rollinson, J.L. Wiemels, and E. Roman Low NAD(P)H: quinine oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults Blood 97 2001 1422 1426
20. A. Clairmont, H. Sies, S. Ramchandran, J.T. Lear, A.G. Smith, and B. Bowers Association of NAD(P)H: quinone oxidoreductase (NQO1) with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci Carcinogenesis 20 1999 1235 1240
21. W.A. Schulz, A. Krummeck, I. Rosinger, P. Eicklmann, C. Neuhaus, and T. Ebert Increased frequency of the null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies Pharmacogenetics 7 1997 235 239
22. M.J. Lafuente, X. Casterad, M. Trias, C. Ascaso, R. Molina, and A. Ballesta NAD(P)H: quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors Carcinogenesis 21 2000 1813 1819
23. J.K. Wiencke, M.R. Spitz, A. McMillan, and K.T. Kelsey Lung cancer in Mexican-Americans and African-Americans is associated with the wild type genotype of the NAD(P)H: quinone oxidoreductase polymorphism Cancer Epidemiol., Biomarkers Prev. 6 1997 87 92
24. E.A. Rosvold, K.A. McGlynn, E.D. Lustbader, and K.H. Buetow Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking Pharmacogenetics 5 1995 199 206
25. H. Chen, A. Lum, A. Seifried, L.R. Wilkens, and L. Le Marchand Association of the NAD(P)H: quinone oxidoreductase 609C → T polymorphism with a decreased lung cancer risk Cancer Res. 59 1999 3945 3948
26. N. Hamajima, K. Matsuo, H. Iwata, M. Shinoda, Y. Yamamura, and T. Kato NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese Int. J. Clin. Oncol. 7 2002 103 108
27. L.L. Xu, J.C. Wain, D.P. Miller, S.W. Thurston, L. Su, and T.J. Lynch The NAD(P)H: quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior Cancer Epidemiol., Biomarkers Prev. 10 2001 303 309
28. J.K. Wiencke, S. Pemble, B. Ketterer, and K.T. Kelsey Gene deletion of glutathione S-transferase θ: correlation with induced genetic damage and potential role in endogenous mutagenesis Cancer Epidemiol., Biomarkers Prev. 4 1995 253 259
29. S. Longuemaux, C. Deloménie, C. Gallou, A. Méjean, M. Vincent-Viry, and R. Bouvier Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes Cancer Res. 59 1999 2903 2908
30. K.J. Helzlsouer, O. Selmin, H.Y. Huang, P.T. Strickland, S. Hoffman, and A.J. Alberg Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer J. Natl. Cancer Inst. 90 1998 512 518
31. S.K. Park, K.Y. Yoo, S.J. Lee, S.U. Kim, S.H. Ahu, and D.Y. Noh Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk Pharmacogenetics 10 2000 301 309
32. T. Zhen, T.R. Hanford, S.H. Sham, P.H. Owens, P. Boyle, and Y. Zhang Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk Br. J. Cancer 88 2003 58 62
33. L. Le March, L. Sivaraman, L. Pierce, A. Seifried, A. Lum, and L.R. Wilkens Association of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens Cancer Res. 58 1998 4858 4863
34. S.J. London, J.M. Yuan, F.L. Chung, Y.T. Gao, G.A. Coetzee, and R.K. Ross Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China Lancet 356 2000 724 729
35. M.R. Spitz, C.M. Duphorne, M.A. Detry, P.C. Pillow, C.I. Amos, and L. Lei Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk Cancer Epidemiol., Biomarkers Prev. 9 2000 1017 1020
36. N. Sunaga, T. Kohno, N. Yanagitani, H. Sugimura, H. Kunitoh, and T. Tamura Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility Cancer Epidemiol., Biomarkers Prev. 11 2002 730 738
37. E. Taioli, L. Gaspari, S. Benhamou, P. Boffetta, J. Brockmoller, and D. Butkiewicz Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years Int. J. Epidemiol. 32 2003 60 63
38. A.P. Warwick, C.W.E. Redman, P.W. Jones, A.A. Fryer, J. Gilford, and J. Alldersea Progression of cervical intraepithelial neoplasia to cervical cancer: interaction of cytochrome P450 CYP2D6 EM and glutathione S-transferase GSTM1 null genotypes and cigarette smoking Br. J. Cancer 70 1994 704 708
39. C. Chen, M.M. Madeleine, N.S. Weiss, and J.R. Darling Glutathione S-transferase M1 genotypes and the risk of squamous carcinoma of the cervix: a population-based case-control study Am. J. Epidemiol. 150 1999 568 572
40. J.W. Kim, C.G. Lee, Y.G. Park, K.S. Kim, I. Kim, and Y.W. Sohn Combined analysis of germline polymorphism of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1 Cancer 88 2002 2082 2091
41. M.T. Goodman, K. McDuffie, M.S. Brenda Hernandez, C.C. Bertram, L.R. Wilkens, and C. Guo CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population Gynecol. Oncol. 81 2001 263 269
42. G. Riou, M. Barrois, and D. Zhou Expression of anionic glutathione S transferase (GSTπ) gene in carcinomas of the uterine cervix and in normal cervices Br. J. Cancer 63 1991 191 194
43. S.H. Jee, J.E. Lee, S. Kim, J.H. Kim, S.J. Um, and S.J. Lee GSTP1 polymorphism, cigarette smoking and cervical cancer risk in Korean women Yonsei Med. J. 43 2002 712 716
44. N. Hamajima, K. Matsuo, T. Saito, H. Kaoru, M. Inoue, and T. Takezaki Gene-environment interaction and polymorphism studies for cancer risks in the Hospital-based Epidemiologic and Research Program at Aichi Cancer Center II (HERPACC-II) Asian Pac. J. Cancer Prev. 2 2001 99 107
45. H. Kawase, N. Hamajima, A. Tamakoshi, K. Wakai, T. Saito, and K. Tajima Triplex polymerase chain reaction with confronting two-pair primers (PCR-CTPP) for NQO1 C609T, GSTM1 and GSTT1 polymorphisms: a convenient genotyping method Asian Pac. J. Cancer Prev. 4 2003 67 70
46. Q. Yang, M.J. Khoury, and W.D. Flanders Sample size requirements in case-only designs to detect gene-environment interaction Am. J. Epidemiol. 146 1997 713 720
47. S.E. Barton, P.H. Maddox, D. Jenkins, R. Edwards, J. Cuzick, and A. Singer Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet 2 1998 652 654
48. L.R. Garrett, N. Perez-Reyes, P.P. Smith, and J.K. McDougall Interaction of human papillomavirus-18 and nitrosomethylurea in the induction of malignancy Carcinogenesis 14 1993 329 332
49. L.A. Brinton, K.T. Tashima, H.F. Lehman, R.S. Levine, K. Mallin, and D.A. Savitz Epidemiology of cervical cancer by cell type Cancer Res. 47 1987 1706 1711
50. M.P. Hopkins, and G.W. Morley A comparison of adenocarcinoma and squamous cell carcinoma of the cervix Obstet. Gynecol. 77 1991 912 917
51. M. Thomas, D. Pim, and L. Banks The role of the E6-p53 interaction in the molecular pathogenesis of HPV Oncogene 18 1999 7690 7700
52. N. Hamajima, T. Takezaki, and T. Tajima Allele frequencies of 25 polymorphisms pertaining to cancer risk for Japanese, Koreans and Chinese Asian Pac. J. Cancer Prev. 3 2002 197 206